News & Analysis on Clinical Trial Services & Contract Research And Development
With operations in more than 100 countries, the world’s largest CRO Quintiles is now looking to extend its global reach even farther, CEO Tom Pike told investors at the Barclays Global Healthcare Conference on Tuesday.
The Danish and Austrian authorities have warned against toxic food supplements ahead of an EU-wide safety logo set to crack down on illegal retailers posing as online pharmacies.
J&J unit McNeil-PPC has admitted breaking US law by selling contaminated liquid medications, including Infants’ Tylenol and Children’s Motrin, deemed adulterated under the federal Food, Drug and Cosmetic Act (FDCA).
Cancer Drug firms trying to block protein kinase Cs should rethink say researchers behind a study indicating that the enzymes suppress tumour development.
Pfizer will continue to make Lipitor at its plant in Little Island, Ireland after an increase in demand for the cholesterol buster.
Biosimilars will mean more facility inspections and reviews according to the US FDA, which is confident its funding will be increased accordingly.
The US FDA has turned to smartphone technology to fight drug shortages with an app aimed at doctors, pharmacists and patients.
Early phase clinical research service provider Altasciences is forming a strategic alliance with ITR Laboratories, a nonclinical services organization, to help more mutual clients customize their drug development programs from lead candidate selection to...